<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00982605</url>
  </required_header>
  <id_info>
    <org_study_id>MK01</org_study_id>
    <nct_id>NCT00982605</nct_id>
  </id_info>
  <brief_title>EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)</brief_title>
  <official_title>EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of
      non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle
      aspiration (EBUS-TBNA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome.
      EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve
      mediastinal staging.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">January 2011</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Non Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>non small cell lung cancer</arm_group_label>
    <description>cancer patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBUS_TBNA</intervention_name>
    <description>EBUS during bronchoscopy</description>
    <arm_group_label>non small cell lung cancer</arm_group_label>
    <other_name>EBUS-TBNA scope, Olympus Medical</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      lymph nodes
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with operable non-small cell lung cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years

          -  Samples are collected before surgery or before any therapy

          -  ECOG 0 or 1

          -  Clinical stage I-II, T1-2, N0-1, M0)

          -  Surgically respectable

          -  Patient with enlarged med. lymphnodes (control group)

        Exclusion Criteria:

          -  Previous RT/CHT

          -  Previous or current cancer of other entity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kreuter, MD</last_name>
    <role>Study Director</role>
    <affiliation>Thoraxklinik Heidelberg, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Kreuter, MD</last_name>
    <phone>49 / 6221 / 396</phone>
    <phone_ext>1201</phone_ext>
    <email>michael.kreuter@thoraxklinik-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Kreuter, MD</last_name>
      <phone>49 / 6221 / 396</phone>
      <phone_ext>1201</phone_ext>
      <email>michael.kreuter@thoraxklinik-heidelberg.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Herth FJ, Annema JT, Eberhardt R, Yasufuku K, Ernst A, Krasnik M, Rintoul RC. Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer. J Clin Oncol. 2008 Jul 10;26(20):3346-50. doi: 10.1200/JCO.2007.14.9229. Epub 2008 Jun 2.</citation>
    <PMID>18519953</PMID>
  </reference>
  <reference>
    <citation>Herth FJ, Eberhardt R. Actual role of endobronchial ultrasound (EBUS). Eur Radiol. 2007 Jul;17(7):1806-12. Epub 2007 Jan 6.</citation>
    <PMID>17206430</PMID>
  </reference>
  <reference>
    <citation>Herth FJ, Ernst A, Eberhardt R, Vilmann P, Dienemann H, Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J. 2006 Nov;28(5):910-4. Epub 2006 Jun 28.</citation>
    <PMID>16807262</PMID>
  </reference>
  <reference>
    <citation>Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax. 2006 Sep;61(9):795-8. Epub 2006 May 31.</citation>
    <PMID>16738038</PMID>
  </reference>
  <reference>
    <citation>Al-Haddad M, Wallace MB. Molecular diagnostics of non-small cell lung cancer using mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Cytopathology. 2006 Feb;17(1):3-9. Review.</citation>
    <PMID>16417559</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2009</study_first_submitted>
  <study_first_submitted_qc>September 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2009</study_first_posted>
  <last_update_submitted>October 5, 2009</last_update_submitted>
  <last_update_submitted_qc>October 5, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof. Felix Herth</name_title>
    <organization>Thoraxklinik Heidelberg</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

